Synthesis and Characterization of Process-Related Impurities of Antidiabetic Drug Linagliptin
Linagliptin, a xanthine derivative, is a highly potent, selective, long-acting and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes. During the process development of linagliptin, five new process-related impurities were detected by high performance liquid chromatography (HPL...
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
MDPI AG
2016-08-01
|
| Sarja: | Molecules |
| Aiheet: | |
| Linkit: | http://www.mdpi.com/1420-3049/21/8/1041 |